JPRN-UMIN000022803已完成未知
Immunogenicity and safety of quadrivalent meningococcal polysaccharide-protein conjugate vaccine among Japanese people aged >=56 years - Immunogenicity and safety of quadrivalent meningococcal polysaccharide-protein conjugate vaccine among Japanese people aged >=56 years
Tokyo Medical University Hospital Travellers' Medical Center0 个研究点目标入组 23 人开始时间: 2016年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 56years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •acute febrile illness immunodeficiency allergy against vaccine contents
研究者
相似试验
进行中（未招募）
4 期
Meningococcal vaccine for 56 years old or olderJPRN-jRCT1061190014Tanaka Takaaki20
招募中
4 期
MENPI: Safety and immunogenicity following meningococcal and pneumococcal immunization among adult people living with HIV. A single center, non-blinded, randomized clinical trial2024-516961-35-01Hvidovre Hospital55
招募中
1 期
Meningococcal B vaccine in patients with aspleniaSplenectomyMedDRA version: 20.0Level: PTClassification code: 10041642Term: Splenectomy Class: 100000004865CTIS2023-508192-36-00Medical University of Vienna80
进行中（未招募）
不适用
Studies on evaluation of immunogenicity of meningococcal vaccine in KoreaCertain infectious and parasitic diseasesKCT0002460Ewha Womans University Medical Center90
已完成
3 期
Study of the Quadrivalent Influenza Vaccine in Participants 6 Months of Age and Older in IndiaCTRI/2021/11/037841Sanofi Healthcare India Private Limited SHIP400